Eric G. Carter - May 21, 2025 Form 4 Insider Report for AEON Biopharma, Inc. (AEON)

Role
Director
Signature
/s/ Alexander Wilson, as attorney-in-fact for Eric G. Carter
Stock symbol
AEON
Transactions as of
May 21, 2025
Transactions value $
$0
Form type
4
Date filed
5/23/2025, 04:50 PM
Previous filing
Sep 4, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Carter Eric G Director 5 PARK PLAZA, SUITE 1750, IRVINE /s/ Alexander Wilson, as attorney-in-fact for Eric G. Carter 2025-05-23 0001387660

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AEON Restricted Stock Units Award $0 +309K $0.00 309K May 21, 2025 Class A Common Stock 309K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") will be settled in cash based on the fair market value of the Issuer's Class A Common Stock on the applicable vesting date.
F2 100% of the RSUs shall vest in full on the one year anniversary of May 21, 2025.